Smith J W, Shulman H M, Thomas E D, Fefer A, Buckner C D
Cancer. 1981 Nov 15;48(10):2198-203. doi: 10.1002/1097-0142(19811115)48:10<2198::aid-cncr2820481014>3.0.co;2-m.
Four patients with acute myelosclerosis were treated with chemoradiotherapy and bone marrow transplantation. Three of the four had prompt engraftment with greater than 0.10 X 10(9) granulocytes/liter three weeks after transplantation. One patient continues in complete remission one year after transplantation. One patient experienced a partial remission and two patients died early in the post-transplantation period. Marrow fibrosis disappeared in three of the four patients. The patient with residual marrow fibrosis died 22 days after transplantation. It is apparent that marrow fibrosis is reversible. In view of the absence of other effective therapy, intensive therapy with marrow transplantation should be considered as primary therapy for patients with acute myelosclerosis who have a suitable marrow donor.
4例急性骨髓硬化症患者接受了放化疗及骨髓移植治疗。4例中有3例在移植后3周迅速植入,粒细胞计数大于0.10×10⁹/升。1例患者在移植后1年持续完全缓解。1例患者部分缓解,2例患者在移植后早期死亡。4例患者中有3例骨髓纤维化消失。有残余骨髓纤维化的患者在移植后22天死亡。显然,骨髓纤维化是可逆的。鉴于缺乏其他有效治疗方法,对于有合适骨髓供体的急性骨髓硬化症患者,应考虑将强化骨髓移植治疗作为主要治疗方法。